Direxion Daily Pharmaceutical & Medical Bull 3X ETF
$16.85−2.14 (−11.27%)
- Expense ratio
- 1.22%
- Fund size
- $20M
- 1Y return
- +155.1%
- Yield · Last 12 months
- 0.36%
- Holdings
- 50
- Volume · 30D
- 0.1M sh
- NAV per share
- $18.16
- 52W range
The ETF.net PILL Grade
Score 26 of 100 sits in the D band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E.
Cost
What you pay to own it — the expense ratio plus trading frictions, ranked within its category.FScore 13Category rankMission
How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.Not scoredRisk
How violently it can move — volatility, drawdown depth, and downside capture versus its category.BScore 61Category rankTradability
How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.FScore 21Category rankHoldings
What it actually owns — the quality, breadth, and concentration of the underlying portfolio.Not scoredDurability
Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.DScore 25Category rank
Our read on PILL
DPharma with the volume knob at 3x. PILL aims for 300% of the daily move in an equal-weighted index of US drugmakers, a rare single-industry leveraged bet where a small-cap counts about as much as a giant. The daily reset makes it a short-horizon tool.
The fund seeks daily investment results, before fees and expenses, equal to 300% of the performance of the S&P Pharmaceuticals Select Industry Index.
Why people hold it
- One of the few US funds offering 3x daily exposure to a single industry: it targets 300% of the daily move of the S&P Pharmaceuticals Select Industry Index, with the leverage reset every day.direxion.com
- The index is modified equal-weighted across the pharmaceutical names in the S&P Total Market Index, so its roughly 50 holdings give mid- and small-cap drugmakers real weight instead of burying them under the mega-caps.finance.yahoo.com
- Live since 2017 from Direxion, a house built around daily leveraged and inverse funds, so the plumbing has run through several drug-pricing and biotech cycles.direxion.com
Worth knowing
- At 1.22% a year it costs more than broad-index 3x peers like FAS (0.92%) and UDOW (0.95%). Leverage on a niche industry is priced accordingly.
- Hold past one day and the math shifts: returns follow the path, and choppy stretches can erode value even if pharma ends up where it started. Direxion states the fund should not be expected to deliver 3x the index's cumulative return beyond a day.direxion.com
- It is non-diversified and tied to one industry, and it does not trade with the depth of the headline broad-market 3x funds, so spreads and order type matter more on entry and exit.finance.yahoo.com
PILL Holdings
- Stocks
- 50
- 79%
- SPSIPH SWAP ASSET LEG (SPSIPHCTL)
Sectors
- Health Care100.0%
Geography
- United States98.27%
- Ireland1.73%
PILL Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | PILL |
|---|---|
| Year to date | +54.7% |
| 1 month | −16.8% |
| 3 months | +28.3% |
| 1 year | +155.1% |
| 3 years | +37.3% |
| 5 years | +2.7% |
| 10 years | — |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | PILL |
|---|---|---|
| 2026 YTD | +54.7% | |
| 2025 | +75.1% | |
| 2024 | −7.3% | |
| 2023 | −12.1% | |
| 2022 | −43.2% | |
| 2021 | −37.3% | |
| 2020 | +0.3% |
PILL in the news
ETF.net Research hasn’t filed on PILL yet — coverage lands here as it’s written.
PILL Dividends
- 0.36%
- $0.07
- $0.02 per share
- Quarterly
Distribution history
| Ex-date | Pay date | Amount per share |
|---|---|---|
| Jun 23, 2026 | Jun 30, 2026 | $0.02 |
| Mar 24, 2026 | Mar 31, 2026 | $0.01 |
| Dec 23, 2025 | Dec 31, 2025 | $0.03 |
| Sep 23, 2025 | Sep 30, 2025 | $0.0099 |
| Jun 24, 2025 | Jul 1, 2025 | $0.02 |
| Mar 25, 2025 | Apr 1, 2025 | $0.02 |
| Dec 23, 2024 | Dec 31, 2024 | $0.01 |
| Sep 24, 2024 | Oct 1, 2024 | $0.03 |
| Jun 25, 2024 | Jul 2, 2024 | $0.02 |
| Mar 19, 2024 | Mar 26, 2024 | $0.03 |
| Dec 21, 2023 | Dec 29, 2023 | $0.04 |
| Sep 19, 2023 | Sep 26, 2023 | $0.04 |
PILL Risk
This fund targets a multiple of the daily move of its index and resets daily. Hold it longer than one reset and compounding makes the return diverge from that target. In choppy markets it can lose value even when the index ends flat.
- 64.4%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 0.65
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −82.0%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 1.76
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
PILL Cost
- The middle half of 3x Leveraged Long funds
- Median 0.98%
25 of the 30 3x Leveraged Long funds charge less.